EU decision on Russia's Sputnik V shot 'impossible' this year - source

The EU drug regulator is unlikely to decide whether to approve Russia's Sputnik V coronavirus vaccine until at least the first quarter of 2022 because some data needed for the review is still missing, a source with knowledge of the matter said. 'An EMA decision by the end of the year is now absolutely impossible,' the source said, referring to the European Medicines Agency. If the required data is received by the end of November, 'then the regulators may well decide in the first quarter of next year', he said.